* FDA advisers concerned about missing data, bleeding risks
* FDA advisers concerned about missing data, bleeding risks
An FDA advisory panel recommends against approval of Johnson & Johnson's ( JNJ ) Xarelto blood thinner to reduce life-threatening blood clots. JNJ already markets the pill to treat irregular heartbeat and patients undergoing hip or knee replacement surgery. Post your comment!
SILVER SPRING, Md., May 23 (Reuters) - A U.S. advisory panel rebuffed Johnson & Johnson's blood thinner, meant to reduce the risk of new heart attacks and strokes in people with heart problems.
… Review meeting the company had with the U.S. Food and Drug Administration ( FDA ). In March the FDA issued CHTP a complete response letter (CRL ..... article . Too Good To Be True? In the CRL the FDA informed Chelsea that no single site shall …
Chelsea Therapeutics International, Ltd. ( CHTP ) Completion of EoR Meeting with FDA for Northera Capsules NDA May 23, 2012 8:30 AM ET Executives Kathryn McNeil – Head-Investor & Media Relations Simon Pedder …
… taxes.Restrictions imposed by the FDA could hamper manufacturers' efforts ..... volume is in secular decline, and the Food and Drug Administration , having assumed regulatory control ..... market share. For example, if the FDA encroaches on manufacturers' ability …
… Ironwood Pharmaceuticals ( IRWD ) received a setback at the FDA that allows SGYP an extra three months to play catch up in the ..... bowel syndrome (IBS-C). Linaclotide is already before the FDA for review, although the review was delayed by three months …
CareFusion ( CFN +0.2% ) receives an FDA warning letter regarding a manufacturing site in Mexico where it ..... that a company follow up dated February 13 was not adequate. The FDA claims that CFN 's facility, Productos Urologos de Mexico SA …
… Congress changing the rules--whether it's Medicare reimbursement, nationalized health care, or stricter Food and Drug Administration guidelines--which could potentially hammer all stocks in this portfolio to some degree. But by buying …